135 related articles for article (PubMed ID: 20007106)
1. The chronic myeloid leukemia stem cell.
Nicholson E; Holyoake T
Clin Lymphoma Myeloma; 2009; 9 Suppl 4():S376-81. PubMed ID: 20007106
[TBL] [Abstract][Full Text] [Related]
2. Getting to the stem of chronic myeloid leukaemia.
Savona M; Talpaz M
Nat Rev Cancer; 2008 May; 8(5):341-50. PubMed ID: 18385684
[TBL] [Abstract][Full Text] [Related]
3. Chronic myeloid leukemia stem cells.
Kavalerchik E; Goff D; Jamieson CH
J Clin Oncol; 2008 Jun; 26(17):2911-5. PubMed ID: 18539972
[TBL] [Abstract][Full Text] [Related]
4. Characterization and selection of benign stem cells in chronic myeloid leukemia.
Lemoli RM
Haematologica; 1993; 78(6):393-400. PubMed ID: 8175034
[TBL] [Abstract][Full Text] [Related]
5. [Kinetics of proliferation, differentiation and transcription of genes regulating apoptosis in cultured human BCR/ABL+ Ph+-cells].
Akhlynina TV; Gerasimova LP; Sarkisian GP; Borovkova TV; Dukhovenskaia EA; Manakova TE; Naĭdenova NM; Timofeev AM; Grineva NI
Tsitologiia; 2007; 49(10):889-900. PubMed ID: 18074781
[TBL] [Abstract][Full Text] [Related]
6. The INK4-ARF (CDKN2A/B) locus in hematopoiesis and BCR-ABL-induced leukemias.
Williams RT; Sherr CJ
Cold Spring Harb Symp Quant Biol; 2008; 73():461-7. PubMed ID: 19028987
[TBL] [Abstract][Full Text] [Related]
7. Chronic myeloid leukemia blast crisis arises from progenitors.
Michor F
Stem Cells; 2007 May; 25(5):1114-8. PubMed ID: 17218393
[TBL] [Abstract][Full Text] [Related]
8. Bcr-Abl expression levels determine the rate of development of resistance to imatinib mesylate in chronic myeloid leukemia.
Barnes DJ; Palaiologou D; Panousopoulou E; Schultheis B; Yong AS; Wong A; Pattacini L; Goldman JM; Melo JV
Cancer Res; 2005 Oct; 65(19):8912-9. PubMed ID: 16204063
[TBL] [Abstract][Full Text] [Related]
9. Stem cell regulation and the development of blast crisis in chronic myeloid leukemia: Implications for the outcome of Imatinib treatment and discontinuation.
Wodarz D
Med Hypotheses; 2008; 70(1):128-36. PubMed ID: 17566666
[TBL] [Abstract][Full Text] [Related]
10. Instability of BCR-ABL gene in primary and cultured chronic myeloid leukemia stem cells.
Jiang X; Saw KM; Eaves A; Eaves C
J Natl Cancer Inst; 2007 May; 99(9):680-93. PubMed ID: 17470736
[TBL] [Abstract][Full Text] [Related]
11. Retroviral insertional mutagenesis identifies RUNX genes involved in chronic myeloid leukemia disease persistence under imatinib treatment.
Miething C; Grundler R; Mugler C; Brero S; Hoepfl J; Geigl J; Speicher MR; Ottmann O; Peschel C; Duyster J
Proc Natl Acad Sci U S A; 2007 Mar; 104(11):4594-9. PubMed ID: 17360569
[TBL] [Abstract][Full Text] [Related]
12. Differences between normal and CML stem cells: potential targets for clinical exploitation.
Eaves AC; Barnett MJ; Ponchio L; Cashman JD; Petzer AL; Eaves CJ
Stem Cells; 1998; 16 Suppl 1():77-83; discussion 89. PubMed ID: 11012149
[TBL] [Abstract][Full Text] [Related]
13. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow derived mesenchymal stem cells from chronic myeloid leukemia t(9;22) patients are devoid of Philadelphia chromosome and support cord blood stem cell expansion.
Jootar S; Pornprasertsud N; Petvises S; Rerkamnuaychoke B; Disthabanchong S; Pakakasama S; Ungkanont A; Hongeng S
Leuk Res; 2006 Dec; 30(12):1493-8. PubMed ID: 16839603
[TBL] [Abstract][Full Text] [Related]
15. Consequences of BCR-ABL expression within the hematopoietic stem cell in chronic myeloid leukemia.
Kabarowski JH; Witte ON
Stem Cells; 2000; 18(6):399-408. PubMed ID: 11072027
[TBL] [Abstract][Full Text] [Related]
16. Hemangioblastic characteristics of cancer stem cells in chronic myeloid leukemia.
Xishan Z; Xu Z; Lawei Y; Gang L
Clin Lab; 2012; 58(7-8):607-13. PubMed ID: 22997961
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of leukemia-initiating capacity of chronic myelogenous leukemia stem cells.
Zhang B; Li L; Ho Y; Li M; Marcucci G; Tong W; Bhatia R
J Clin Invest; 2016 Mar; 126(3):975-91. PubMed ID: 26878174
[TBL] [Abstract][Full Text] [Related]
18. Multilineage outgrowth of both malignant and normal hemopoietic progenitor cells from individual chronic myeloid leukemia patients in immunodeficient mice.
Verstegen MM; Cornelissen JJ; Terpstra W; Wagemaker G; Wognum AW
Leukemia; 1999 Apr; 13(4):618-28. PubMed ID: 10214871
[TBL] [Abstract][Full Text] [Related]
19. Selective elimination of leukemia stem cells: hitting a moving target.
Crews LA; Jamieson CH
Cancer Lett; 2013 Sep; 338(1):15-22. PubMed ID: 22906415
[TBL] [Abstract][Full Text] [Related]
20. Leukemia stem cells.
Testa U
Ann Hematol; 2011 Mar; 90(3):245-71. PubMed ID: 21107841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
